# MDMetrix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mdmetrix

- Industry: Healthcare IT
- Headquarters: Seattle, US
- Website: www.mdmetrix.com
- Total disclosed funding: $9M
- Latest round: Series A (Jul 28, 2021)
- Investors on record: 5

## About

AdaptX, Inc. is a Seattle-based company that develops advanced solutions for managing clinical variances in healthcare, enhancing operational efficiency, and improving care quality across diverse medical settings.Founded in 2016 in Seattle, US, AdaptX, Inc. specializes in adaptive clinical management technology. The company has successfully raised USD 8.00 mn through various funding rounds, with the latest funding round occurring on August 25, 2023, where it secured USD 10.00 mn led by Cercano Management and supported by other notable investors. The CEO of AdaptX is Warren Ratliff, and Matthew Goos is one of the founders, known for his contributions to the healthcare technology sector.AdaptX specializes in delivering advanced solutions that enable clinical leaders to manage variation in care across healthcare settings, including academic medical centers and critical access hospitals. Its core offerings focus on optimizing workflows, enhancing operational efficiency, and improving care quality through real-time data insights. The platform empowers users—such as clinical leaders and healthcare teams—to analyze their own real-world clinical data, facilitating the identification of best practices and operational adjustments. This approach helps address challenges like capacity, revenue management, quality improvement, health equity, and sustainability. AdaptX serves a diverse client base, including healthcare organizations such as Seattle Children's Hospital and Kittitas Valley Healthcare, primarily within the United States.AdaptX operates on a business model that includes subscription-based services, where healthcare organizations pay for access to the platform and its suite of analytical tools. Clients engage in transactions directly with AdaptX, utilizing features that allow for the management of clinical variations and improvement of operational efficiency. This pricing structure caters to healthcare institutions of various sizes, ensuring effective use of the platform. The services offered by AdaptX assist in generating revenue by optimizing surgical capacity and managing resource allocation, which are critical for financial sustainability in the healthcare sector. The company's solutions have been instrumental in driving improvements in both clinical outcomes and operational performance, aligning with industry priorities.In November 2023, AdaptX, Inc. raised USD 10.00 mn in venture funding to bolster its adaptive clinical management technology. The company aims to leverage this funding to expand its product offerings and enhance its market presence. Upcoming initiatives include the development of new products designed to optimize healthcare processes further, with a focus on entering new geographic markets by 2025. AdaptX plans to target regions that can benefit significantly from its technology, expanding its services to improve healthcare delivery and efficiency.

## Funding rounds

- Series A, Jul 28, 2021, $6M — Vulcan, Founders' Co-op, WRF Capital, Alumni Ventures Group, Arnold Venture Group
- Seed, May 14, 2019, $3M — Founders' Co-op, WRF Capital, Arnold Venture Group

## Investors

- Founders' Co-op (https://capitalatlas.ai/funds/founders-co-op) — Seed, Series A
- WRF Capital (https://capitalatlas.ai/funds/wrf-capital) — Seed, Series A
- Arnold Venture Group (https://capitalatlas.ai/funds/arnold-venture-group) — Seed, Series A
- Vulcan (https://capitalatlas.ai/funds/vulcan) — Series A
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series A